Refractory Primary Central Nervous System Lymphoma

specific

A primary central nervous system lymphoma that is resistant to treatment. The vast majority of cases are non-Hodgkin lymphomas.

17

Centers

18

Active Trials

Cancer Funding

Top Centers for Refractory Primary Central Nervous System Lymphoma(17)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
74.1
2
NCI Comprehensive
Active Research Program
51.6
3
NCI Comprehensive
Active Research Program
51.6
4
NCI Comprehensive
Active Research Program
51.6
5
NCI Comprehensive
Active Research Program
51.6
6
NCI Comprehensive
Active Research Program
51.6
7
NCI Comprehensive
Active Research Program
51.6
8
NCI Comprehensive
Active Research Program
51.6
9
NCI Comprehensive
Active Research Program
51.6
10
NCI Comprehensive
Active Research Program
51.6
11
Active Research Program
51.6
12
NCI Clinical
Active Research Program
51.6
13
Active Research Program
51.6
14
Active Research Program
51.6
15
Active Research Program
51.6
16
Active Research Program
51.6
17
Active Research Program
51.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →